Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolley E Johnson

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Experimental and Clinical Psychopharmacology|December 22, 2005
Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependenceLisa A Marsch, Mary Ann Chutuape Stephens, Timothy Mudric, et al.
Clinical Chemistry|January 20, 2011
Maternal methadone dose, placental methadone concentrations, and neonatal outcomesAna de Castro, Hendreé E Jones, Rolley E Johnson, et al.
Therapeutic Drug Monitoring|July 2, 2010
Excretion of methadone in sweat of pregnant women throughout gestation after controlled methadone administrationAllan J Barnes, Bertrand R Brunet, Robin E Choo, et al.
Therapeutic Drug Monitoring|April 13, 2012
Methadone and metabolites in hair of methadone-assisted pregnant women and their infantsSarah K Himes, Robert S Goodwin, Colleen M Rock, et al.
Journal of Substance Abuse Treatment|April 29, 2005
Influence of psychotherapy attendance on buprenorphine treatment outcomeIván D Montoya, Jennifer R Schroeder, Kenzie L Preston, et al.
Drug and Alcohol Dependence|December 23, 2003
Open-label trial of an injection depot formulation of buprenorphine in opioid detoxificationBai-Fang X Sobel, Stacey C Sigmon, Sharon L Walsh, et al.
Clinical Chemistry|October 9, 2007
Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administrationRobert S Goodwin, Diana G Wilkins, Olga Averin, et al.
Drug and Alcohol Dependence|September 22, 2009
Case histories in pharmaceutical risk managementCynthia G McCormick, Jack E Henningfield, J David Haddox, et al.
Clinical Pharmacology and Therapeutics|January 30, 2004
Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependenceIvan D Montoya, David A Gorelick, Kenzie L Preston, et al.
Drug and Alcohol Dependence|June 10, 2005
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndromeHendree E Jones, Rolley E Johnson, Donald R Jasinski, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Experimental and Clinical Psychopharmacology|December 22, 2005
Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependenceLisa A Marsch, Mary Ann Chutuape Stephens, Timothy Mudric, et al.
Clinical Chemistry|January 20, 2011
Maternal methadone dose, placental methadone concentrations, and neonatal outcomesAna de Castro, Hendreé E Jones, Rolley E Johnson, et al.
Therapeutic Drug Monitoring|July 2, 2010
Excretion of methadone in sweat of pregnant women throughout gestation after controlled methadone administrationAllan J Barnes, Bertrand R Brunet, Robin E Choo, et al.
Therapeutic Drug Monitoring|April 13, 2012
Methadone and metabolites in hair of methadone-assisted pregnant women and their infantsSarah K Himes, Robert S Goodwin, Colleen M Rock, et al.
Journal of Substance Abuse Treatment|April 29, 2005
Influence of psychotherapy attendance on buprenorphine treatment outcomeIván D Montoya, Jennifer R Schroeder, Kenzie L Preston, et al.
Drug and Alcohol Dependence|December 23, 2003
Open-label trial of an injection depot formulation of buprenorphine in opioid detoxificationBai-Fang X Sobel, Stacey C Sigmon, Sharon L Walsh, et al.
Clinical Chemistry|October 9, 2007
Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administrationRobert S Goodwin, Diana G Wilkins, Olga Averin, et al.
Drug and Alcohol Dependence|September 22, 2009
Case histories in pharmaceutical risk managementCynthia G McCormick, Jack E Henningfield, J David Haddox, et al.
Clinical Pharmacology and Therapeutics|January 30, 2004
Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependenceIvan D Montoya, David A Gorelick, Kenzie L Preston, et al.
Drug and Alcohol Dependence|June 10, 2005
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndromeHendree E Jones, Rolley E Johnson, Donald R Jasinski, et al.
Pageof 3